These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18337056)

  • 1. Reduction of blood lipid by berberine in hyperlipidemic patients with chronic hepatitis or liver cirrhosis.
    Zhao W; Xue R; Zhou ZX; Kong WJ; Jiang JD
    Biomed Pharmacother; 2008 Dec; 62(10):730-1. PubMed ID: 18337056
    [No Abstract]   [Full Text] [Related]  

  • 2. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical trial of heptral in patients with chronic diffuse liver disease with intrahepatic cholestasis syndrome].
    Podymova SD; Nadinskaia MIu
    Klin Med (Mosk); 1998; 76(10):45-8. PubMed ID: 9865018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of chophytol in complex treatment of patients with the chronic forms of hepatitis and cirrhosis of viral etiology].
    Kvitashvili MA; Okrostsvaridze NI; Chitaishvili KP
    Georgian Med News; 2006 Jun; (135):95-8. PubMed ID: 16905821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dynamics of the pathomorphological changes in cirrhotic liver in own material].
    Mietkiewski J
    Przegl Epidemiol; 2005; 59(2):411-4. PubMed ID: 16190548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis A vaccine is not required in adult patients with chronic liver disease in Saudi Arabia.
    Singal AK
    Singapore Med J; 2009 Apr; 50(4):442-3. PubMed ID: 19421692
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical observation on effect of shennong xian'ganling capsule in treating chronic hepatitis and liver cirrhosis].
    Lei L; Ai SM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 May; 24(5):450-2. PubMed ID: 15199634
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum thrombopoietin levels in thrombocytopenic patients with liver cirrhosis.
    Vyzantiadis T; Theodoridou S; Giouleme O; Evgenidis N; Vyzantiadis A; Garipidou V
    Haematologica; 2002 Aug; 87(8):890-1. PubMed ID: 12161370
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of Ursodeoxycholi acid on liver cirrhosis with hepatitis B].
    Wang X; Shen S; Li N; Li Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):171-5. PubMed ID: 20197618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Liver hemosiderosis study in chronic viral hepatitis].
    Cojocariu C; Trifan A; Mihailovici MS; Danciu M; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(4):914-21. PubMed ID: 20209762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changing incidence of liver cirrhosis B and C].
    Yamaguchi N; Hirano M; Inoue O; Yano M
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):648-51. PubMed ID: 12442461
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of pegylated interferon beta-1a therapy on the liver fibrosis in chronic hepatitis C: a semi-quantitative analysis].
    Rao HY; Li J; Zhang LF; Chen HY; Zhu LM; Wei L; Sun Y; Wang H
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):96-100. PubMed ID: 18353212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying the burden of chronic viral hepatitis-related cirrhosis hospitalizations in New Haven County, Connecticut.
    Durante AJ; Meek JI; St Louis T; Navarro VJ; Sofair AN
    Conn Med; 2008 Aug; 72(7):393-7. PubMed ID: 18763666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interconnection in activity of lipid peroxidation reactions and functional status of the liver in patients with chronic hepatitis of viral etiology].
    Tkachev VD; Nilova TV; Shustova SG; Petrakov AV; Sil'vestrova SIu; Drozdov VN
    Eksp Klin Gastroenterol; 2002; (6):35-7, 112. PubMed ID: 12685009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis.
    Schiff E; Simsek H; Lee WM; Chao YC; Sette H; Janssen HL; Han SH; Goodman Z; Yang J; Brett-Smith H; Tamez R
    Am J Gastroenterol; 2008 Nov; 103(11):2776-83. PubMed ID: 18721244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis.
    Loguercio C; Federico A; Masarone M; Torella R; Blanco Cdel V; Persico M
    Am J Gastroenterol; 2008 Dec; 103(12):3159-66. PubMed ID: 18786125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of HBV-related cirrhosis.
    Vallet-Pichard A; Mallet V; Costentin CE; Pol S
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):527-35. PubMed ID: 19485793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression in chronic hepatitis: the virus, the drug, or the ethnic background?
    Ferenci P; Staufer K
    Liver Int; 2008 Apr; 28(4):429-31. PubMed ID: 18339069
    [No Abstract]   [Full Text] [Related]  

  • 20. [Metabolic aspects of the prediction of outcome in chronic viral hepatitis].
    Beloborodova EI; Savchenko IV; Belodorobova EV; Rachkovskiĭ MI; Burkovskaia VA; Abdrashitov RF; Kishchuk IP; Chelnov VG; Dunaeva LE; Varlakova NN; Knutarëva EN
    Klin Med (Mosk); 2005; 83(2):53-6. PubMed ID: 15803834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.